Budesonide Capsule, Coated Pellets
Product Images NDC 0904-7313

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0904-7313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Budesonide (6325fb93 302b 443f Bc10 49e8c0e75b46 01)

Chemical structures of the 22R and 22S epimers of budesonide, depicting the molecular arrangements of this active ingredient used in the oral coated pellets formulation.*

FDA Label Image

3mg Carton Label (E7aca8d1 159e 4aac B92d 3a69a8edceec 00)

Label for Budesonide Delayed-Release Capsules, 3 mg, oral coated pellets. The label indicates a package containing 20 capsules (2 x 10) and is designated for Rx only. The product is distributed by Major Pharmaceuticals with the NDC 0904-7313-10. The label includes storage instructions, dosage suggestion, and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.